ACGT

ACGT aims to present the 'next-step' in cancer research and fill-in the technological gaps of clinical trials targeting two forms of cancer: breast cancer and paediatric nephroblastoma. ACGT will develop a Biomedical GRID infrastructure supporting seamless mediation services for sharing clinical and genomic expertise. It will help to identify quicker and more efficiently the characteristics that determine what form of treatment best suits which patient.

ACGT aims to provide researchers and patients with the best means and resources to fight cancer. ACGT is working towards the rapid identification of cancer profiles and best treatments. The ACGT project will:

  • Define common standards of data storage at each level of investigation.
  • Develop new ontologies for cross-referencing terms and their biological contexts.
  • Implement a bio-medical GRID infrastructure offering seamless mediation services for sharing data and dataprocessing.

ACGT will therefore deliver a unifying infrastructure allowing cancer researchers to share their data and to benefit from the innovative informatics tools that are being developed by other researchers.

For further information, please visit:
http://www.eu-acgt.org

Project co-ordinator:
ERCIM EEIG

Partners:

  • ERCIM EEIG - Institut National de Recherche en Informatique et en Automatique - Healthgrid (FR)
  • Foundation for Research and Technology Hellas - A. Persidis & SIA O.E. - University of Crete - Institute of Communications and Computer Systems (GR)
  • University van Amsterdam - Philips Electronics Nederland B.V. (NL)
  • Association Hospitaliere de Bruxelles – Centre Hospitalier Universitaire Bordet – Custodix - Facultes Universitaires Notre-Dame de la Paix (BE)
  • Institut Suisse de Bioinformatique (CH)
  • Lunds Universitet (SE)
  • Universidad de Malaga - Universidad Politechnica de Madrid (ES)
  • Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung - Unisersitaet Hannover - Universitaet des Saarland - Universitaet Hamburg (DE)
  • Instytut Chemii Biooganicznej pan w Poznaniu (PL)
  • S.C. SIVECO ROMANIA SA (RO)
  • The Chancellor, Masters and Scholars of the University of Oxford (UK)
  • Hokkaido University (JP)
  • Istituto Europeo di Oncologia s.r.l. (IT)

Timetable: from 02/06 - to 01/10

Total cost: € 16. 747.206

EC funding: € 11. 887.000

Instrument: Integrated Project

Project Identifier: IST-2004-026996

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...